Carl Gordon

Carl Gordon

Net worth: 58 170 $ as of 31/08/2026

61 year
Health Technology
Finance
Commercial Services

Profile

Dr. Carl L.
Gordon is an Independent Director at Electra Therapeutics, Inc., a Chairman at Compass Therapeutics, Inc., a Managing Partner at OrbiMed Advisors Private Equity, a Managing Partner at OrbiMed Advisors LLC, an Advisor at The New York City Investment Fund Manager, Inc., an Independent Director at Avenzo Therapeutics, Inc. /New/ and a Principal at Aragon Pharmaceuticals, Inc. He is on the Board of Directors at Lomond Therapeutics Holdings, Inc., Scribe Therapeutics, Inc., Blossomhill Therapeutics, Inc., ADARx Pharmaceuticals, Inc., Electra Therapeutics, Inc., Adimab LLC, Agensys, Inc., Amnis Corp., Emendo Biotherapeutics, Inc., Frontera Therapeutics (HK) Ltd., Gemini Therapeutics Sub, Inc., Gwynant Therapeutics, Inc., Kumquat Biosciences, Inc., Sapphire Therapeutics, Inc., Star OpCo, Inc., Stratus Therapeutics, Inc., X4 Pharmaceuticals (Austria) GmbH, XinThera, Inc. and Avenzo Therapeutics, Inc. /New/.
Dr. Gordon was previously employed as an Independent Director by Arrivent BioPharma, Inc., an Independent Director by MBX Biosciences, Inc., an Independent Director by Keros Therapeutics, Inc., an Independent Director by Kinnate Biopharma, Inc., an Independent Director by Terns Pharmaceuticals, Inc., an Independent Non-Executive Director by Passage Bio, Inc., an Independent Director by Theseus Pharmaceuticals, Inc., an Independent Director by Springworks Therapeutics, Inc., a Lead Independent Director by Turning Point Therapeutics, Inc., an Independent Director by Gemini Therapeutics, Inc., an Independent Director by Oric Pharmaceuticals, Inc., a Chairman by Adicet Bio, Inc., an Independent Director by Intellia Therapeutics, Inc., an Independent Director by Alector, Inc., an Independent Director by Arsanis, Inc., an Independent Director by Selecta Biosciences, Inc., an Independent Director by Complete Genomics, Inc., an Independent Non-Executive Director by Amarin Corp.
Plc, and an Independent Director by Pacira Pharmaceuticals, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2025 5,250 ( 0.03% ) 58 170 $ 31/08/2026
31/03/2026 0 ( -.--% ) - $ 31/08/2026
06/08/2026 0 ( -.--% ) - $ 31/08/2026

Carl Gordon active positions

CompaniesPositionStart
COMPASS THERAPEUTICS, INC. Chairman 01/01/2015
BLOSSOMHILL THERAPEUTICS, INC. Director/Board Member 01/02/2021
ELECTRA THERAPEUTICS, INC. Director/Board Member 01/03/2019
SCRIBE THERAPEUTICS INC. Director/Board Member 01/03/2021
ADARX PHARMACEUTICALS, INC. Director/Board Member 01/01/2020
Founder 01/01/1989
X4 Pharmaceuticals (Austria) GmbH
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░ ░░░░░░░ -

Former positions of Carl Gordon

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Carl Gordon's experience

Training of Carl Gordon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

62

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies62

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

X4 Pharmaceuticals (Austria) GmbH

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology